Ashraf Reda

@cardio-risk.org

Cardiology department, faculty of medicine, Menoufia University
Menoufiya University

Ashraf Reda


            Download Compact PDF  
https://researchid.co/ashrafreda5555

RESEARCH, TEACHING, or OTHER INTERESTS

Cardiology and Cardiovascular Medicine
5062

Scholar Citations

28

Scholar h-index

45

Scholar i10-index

RECENT SCHOLAR PUBLICATIONS

  • Management of Hidradenitis Suppurativa in the United Arab Emirates (UAE): A Consensus Statement from the Emirates Dermatology Society
    A Ameen, F Albreiki, A Alnaeem, M Al Murrawi, HR Ali, R Almaashari, ...
    Dermatology and Therapy, 1-25 , 2026
    2026
  • 2025 Egyptian guidelines for the management of dyslipidemia
    A Reda, HS Taha, HM Badran, H Khamis, S Kamal, AS Elserafy, ...
    The Egyptian Heart Journal 78 (1), 6 , 2026
    2026
  • Genomic and clinical predictors of cardiovascular disease in Familial dyslipidemia: risk stratification in Egyptian adolescents and young adults
    AM Metwally, NM Elaraby, WM Ezzat, MO Dimitry, GA Elshaarawy, ...
    Lipids in Health and Disease , 2025
    2025
  • The Burden of Alopecia Areata and Management with Baricitinib in the United Arab Emirates: A Narrative Review
    HA Dayem, A Al Hammadi, A Reda, F Albreiki, A Al Naeem, A Ameen, ...
    Dermatology and Therapy 15 (12), 3463-3477 , 2025
    2025
    Citations: 1
  • Proposed lipidology and preventive cardiology research priorities in Africa; Results of a Delphi survey
    ARM Lyons, FJ Raal, BS Mansfield, D Marais, NPJ Jessen, LT Appiah, ...
    Atherosclerosis Plus 61, 18-22 , 2025
    2025
  • Egyptian association of vascular biology and atherosclerosis (EAVA) consensus on the usage of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors
    E Farag, A Reda, A Shawky, A Bendary, N Farag, A Elbahry, T Mostafa, ...
    Atherosclerosis 407 , 2025
    2025
  • Egyptian dyslipidemia guidelines
    A Reda, H Salah, H Khamis, A Shawky, A Bendary, M Hasan, A Elmaragy, ...
    Atherosclerosis 407 , 2025
    2025
  • The Atrial FibriLlatiOn Registry (FLOW-AF): Patient Characteristics, Treatment Patterns, and Outcomes in Egypt
    M Sobhy, M Abdelhamid, AM El Etriby, MFS Gamaleldin, AMH Youssef, ...
    Cardiology and Therapy 14 (2), 161-182 , 2025
    2025
    Citations: 1
  • Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry
    A Elshorbagy, AJ Vallejo-Vaz, F Barkas, ARM Lyons, CAT Stevens, ...
    European heart journal 46 (12), 1127-1140 , 2025
    2025
    Citations: 17
  • A collaborative effort across Africa to investigate risk factors and outcomes of premature acute coronary syndrome: Protocol for the EAS Lipid Registry of Africa (LIPRA)
    A Reda, ARM Lyons, A Zambon, A Bendary, M Al-Khnifsawi, H Gamra, ...
    Atherosclerosis Plus 58, 46-50 , 2024
    2024
    Citations: 2
  • Regulatory Framework for Supporting the Integration and Use of Biosimilars in the Private Healthcare System of the United Arab Emirates (UAE)
    M Farghaly, KA El-Fass, N Amin, S Qaiser, M Attallah, Q Farooq, M Badr, ...
    Cureus 16 (11) , 2024
    2024
  • Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross …
    A Elshorbagy, ARM Lyons, AJ Vallejo-Vaz, CAT Stevens, KI Dharmayat, ...
    The Lancet Diabetes & Endocrinology 12 (11), 811-823 , 2024
    2024
    Citations: 13
  • The pattern of lipid lowering therapy for primary and secondary cardiovascular prevention in Egypt; Phase-I of the CEPHEUS-3 study
    A Reda, A Elbahry, M Samy, N Elkafrawy, O Sanad, S Emil, T Moustafa, ...
    Atherosclerosis 395 , 2024
    2024
  • The Egyptian association of vascular biology and atherosclerosis (EAVA) position statement on the usage of Bempedoic acid
    A Reda, AS Elserafy, A Elbahry, E Farag, H Khamis, T Moustafa, ...
    Atherosclerosis 395 , 2024
    2024
  • United Arab Emirates Consensus Recommendations for Management of Acne Vulgaris.
    AA Dhaheri, A Ameen, A Reda, A Alnaeem, KA Nuaimi, FA Marzooqi, ...
    Journal of Drugs in Dermatology: JDD 23 (8), 653-660 , 2024
    2024
  • Sex differences in diagnosis, treatment, and cardiovascular outcomes in homozygous familial hypercholesterolemia
    JWCM Mulder, TR Tromp, M Al-Khnifsawi, DJ Blom, K Chlebus, M Cuchel, ...
    JAMA cardiology 9 (4), 313-322 , 2024
    2024
    Citations: 30
  • Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study
    KI Dharmayat, AJ Vallejo-Vaz, CAT Stevens, JM Brandts, ARM Lyons, ...
    The Lancet 403 (10421), 55-66 , 2024
    2024
    Citations: 66
  • Sodium-Glucose Cotransporter-2 Inhibitors: Who, When & How? Guidance for Use from a Multidisciplinary Practical Approach
    K Abdullah, M ElSharkawy, ER Issak, AS ElSerafy, S Idris, A Bendary, ...
    International Journal of Clinical Medicine 15, 413-435 , 2024
    2024
  • Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study
    K Inamdar Dharmayat, AJ Vallejo-Vaz, CAT Stevens, JM Brandts, ...
    Elsevier , 2024
    2024
  • Hyponatraemia and changes in natraemia during hospitalization for acute heart failure and associations with in-hospital and long-term outcomes–from the ESC-HFA EORP Heart …
    A Kapłon-Cieślicka, L Benson, O Chioncel, MG Crespo-Leiro, AJS Coats, ...
    European Journal of Heart Failure 25 (9), 1571-1583 , 2023
    2023
    Citations: 14

MOST CITED SCHOLAR PUBLICATIONS

  • Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart …
    AP Maggioni, SD Anker, U Dahlström, G Filippatos, P Ponikowski, ...
    European journal of heart failure 15 (10), 1173-1184 , 2013
    2013
    Citations: 915
  • Acute heart failure congestion and perfusion status–impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure …
    O Chioncel, A Mebazaa, AP Maggioni, VP Harjola, G Rosano, C Laroche, ...
    European journal of heart failure 21 (11), 1338-1352 , 2019
    2019
    Citations: 399
  • Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
    AJ Vallejo-Vaz, CAT Stevens, ARM Lyons, KI Dharmayat, T Freiberger, ...
    The Lancet 398 (10312), 1713-1725 , 2021
    2021
    Citations: 342
  • Overview of the current status of familial hypercholesterolaemia care in over 60 countries-The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
    AJ Vallejo-Vaz, M De Marco, CAT Stevens, A Akram, T Freiberger, ...
    Atherosclerosis 277, 234-255 , 2018
    2018
    Citations: 263
  • Reducing the clinical and public health burden of familial hypercholesterolemia: a global call to action
    Representatives of the Global Familial Hypercholesterolemia Community, ...
    JAMA cardiology 5 (2), 217-229 , 2020
    2020
    Citations: 241
  • Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study
    TR Tromp, ML Hartgers, GK Hovingh, AJ Vallejo-Vaz, KK Ray, H Soran, ...
    The Lancet 399 (10326), 719-728 , 2022
    2022
    Citations: 212
  • In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term Registry
    G Targher, M Dauriz, C Laroche, PL Temporelli, M Hassanein, ...
    European journal of heart failure 19 (1), 54-65 , 2017
    2017
    Citations: 196
  • The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP)
    F Zhubi-Bakija, G Bajraktari, I Bytyçi, DP Mikhailidis, MY Henein, ...
    Clinical nutrition 40 (1), 255-276 , 2021
    2021
    Citations: 192
  • Performance of prognostic risk scores in chronic heart failure patients enrolled in the European Society of Cardiology Heart Failure Long-Term Registry
    M Canepa, C Fonseca, O Chioncel, C Laroche, MG Crespo-Leiro, ...
    JACC: Heart Failure 6 (6), 452-462 , 2018
    2018
    Citations: 175
  • Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA …
    P Rossignol, M Lainscak, MG Crespo-Leiro, C Laroche, MF Piepoli, ...
    European Journal of Heart Failure 22 (8), 1378-1389 , 2020
    2020
    Citations: 157
  • Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis …
    SD Wiviott, HD White, EM Ohman, KAA Fox, PW Armstrong, ...
    The Lancet 382 (9892), 605-613 , 2013
    2013
    Citations: 153
  • Management of acute coronary syndromes in developing countries: acute coronary events—a multinational survey of current management strategies
    Access Investigators
    American heart journal 162 (5), 852-859. e22 , 2011
    2011
    Citations: 151
  • Spermatogonial quantity in human prepubertal testicular tissue collected for fertility preservation prior to potentially sterilizing therapy
    JB Stukenborg, JP Alves-Lopes, M Kurek, H Albalushi, A Reda, V Keros, ...
    Human Reproduction 33 (9), 1677-1683 , 2018
    2018
    Citations: 146
  • A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction–insights from the ESC-HFA EORP Heart Failure Long …
    A Kapłon-Cieślicka, L Benson, O Chioncel, MG Crespo-Leiro, AJS Coats, ...
    European journal of heart failure 24 (2), 335-350 , 2022
    2022
    Citations: 136
  • Sex-and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry
    M Lainščak, I Milinković, M Polovina, MG Crespo-Leiro, LH Lund, ...
    European journal of heart failure 22 (1), 92-102 , 2020
    2020
    Citations: 133
  • In vitro differentiation of rat spermatogonia into round spermatids in tissue culture
    A Reda, M Hou, TR Winton, RE Chapin, O Söder, JB Stukenborg
    MHR: Basic science of reproductive medicine 22 (9), 601-612 , 2016
    2016
    Citations: 126
  • Early risks of death, stroke/systemic embolism, and major bleeding in patients with newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry
    JP Bassand, S Virdone, SZ Goldhaber, AJ Camm, DA Fitzmaurice, ...
    Circulation 139 (6), 787-798 , 2019
    2019
    Citations: 99
  • Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)
    PE Penson, E Bruckert, D Marais, Ž Reiner, M Pirro, A Sahebkar, ...
    Journal of cachexia, sarcopenia and muscle 13 (3), 1596-1622 , 2022
    2022
    Citations: 77
  • Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases–A position paper from the International Lipid Expert Panel (ILEP)
    M Ruscica, PE Penson, N Ferri, CR Sirtori, M Pirro, GBJ Mancini, N Sattar, ...
    Progress in Cardiovascular Diseases 67, 40-52 , 2021
    2021
    Citations: 76
  • Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)
    M Rizzo, A Colletti, PE Penson, N Katsiki, DP Mikhailidis, PP Toth, ...
    Pharmacological Research 189, 106679 , 2023
    2023
    Citations: 70